Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for breast fibroadenoma
IRCT20100706004329N7Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in adenofibroma comparing Metformin with Placebo (2 arms). Primary endpoint: Size of the fibroadenoma. Started Sep 2018; status: completed.
02
Drugs
metformin
03
Conditions
adenofibroma
Beyond the preview
Go deeper on IRCT20100706004329N7.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20100706004329N7.